Bevifimod

DB15301Investigational

Bevifimod is under investigation in clinical trial NCT01749787 (Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis).

Mechanism: Pharmacologically active on IgG heavy chain
Curator reviewed
Also known as: STAPHYLOCOCCAL PROTEIN A

Resolves to

Compound

UNIIPNV0H3A73BCAS2223113-32-2

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Bevifimod, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account